Incremental changes in QRS duration as predictor for cardiovascular disease: a 21-year follow-up of a randomly selected general population.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
01 07 2021
Historique:
received: 18 02 2021
accepted: 27 04 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 5 11 2021
Statut: epublish

Résumé

The QRS complex has been shown to be a prognostic marker in coronary artery disease. However, the changes in QRS duration over time, and its predictive value for cardiovascular disease in the general population is poorly studied. So we aimed to explore if increased QRS duration from the age of 50-60 is associated with increased risk of major cardiovascular events during a further follow-up to age 71. A random population sample of 798 men born in 1943 were examined in 1993 at 50 years of age, and re-examined in 2003 at age 60 and 2014 at age 71. Participants who developed cardiovascular disease before the re-examination in 2003 (n = 86) or missing value of QRS duration in 2003 (n = 127) were excluded. ΔQRS was defined as increase in QRS duration from age 50 to 60. Participants were divided into three groups: group 1: ΔQRS < 4 ms, group 2: 4 ms ≤ ΔQRS < 8 ms, group 3: ΔQRS ≥ 8 ms. Endpoints were major cardiovascular events. And we found compared with men in group 1 (ΔQRS < 4 ms), men with ΔQRS ≥ 8 ms had a 56% increased risk of MACE during follow-up to 71 years of age after adjusted for BMI, systolic blood pressure, smoking, hyperlipidemia, diabetes and heart rate in a multivariable Cox regression analysis (HR 1.56, 95% CI:1.07-2.27, P = 0.022). In conclusion, in this longitudinal follow-up over a decade QRS duration increased in almost two out of three men between age 50 and 60 and the increased QRS duration in middle age is an independent predictor of major cardiovascular events.

Identifiants

pubmed: 34211015
doi: 10.1038/s41598-021-93024-y
pii: 10.1038/s41598-021-93024-y
pmc: PMC8249416
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13652

Références

Circulation. 1968 Dec;38(6):1104-15
pubmed: 5721960
Am J Cardiol. 2013 Sep 1;112(5):671-7
pubmed: 23726176
Am J Cardiol. 2014 Apr 1;113(7):1178-83
pubmed: 24513474
J Am Coll Cardiol. 2005 Dec 20;46(12):2183-92
pubmed: 16360044
Eur Heart J. 2009 Dec;30(23):2908-14
pubmed: 19687165
Am J Cardiol. 2002 Jul 1;90(1):24-8
pubmed: 12088774
Am Heart J. 2002 Jun;143(6):1085-91
pubmed: 12075267
Scand Cardiovasc J. 2018 Oct;52(5):256-261
pubmed: 30303692
Am J Cardiol. 2009 Dec 1;104(11):1490-3
pubmed: 19932780
J Am Coll Cardiol. 1998 Aug;32(2):476-82
pubmed: 9708478
Am J Cardiol. 2017 Jun 1;119(11):1757-1762
pubmed: 28416200
JAMA. 2008 Jun 11;299(22):2656-66
pubmed: 18544725
Scand Cardiovasc J. 2020 Apr;54(2):115-123
pubmed: 31674218
J Card Fail. 2008 Dec;14(10):850-5
pubmed: 19041049
Eur J Prev Cardiol. 2020 May;27(7):717-725
pubmed: 31446787
N Engl J Med. 1990 May 31;322(22):1561-6
pubmed: 2139921
Circulation. 2004 Aug 17;110(7):766-9
pubmed: 15289365
Am J Cardiol. 2001 Jul 15;88(2):182-5, A6
pubmed: 11448421
Circ Arrhythm Electrophysiol. 2011 Oct;4(5):704-10
pubmed: 21841194
Arch Intern Med. 1991 Jul;151(7):1365-8
pubmed: 2064487
J Am Heart Assoc. 2018 Apr 19;7(9):
pubmed: 29674335
Heart. 2011 Nov;97(21):1766-70
pubmed: 21835757
Am J Cardiol. 2002 May 1;89(9):1013-8
pubmed: 11988187

Auteurs

Xiaojing Chen (X)

Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. chenxiaojing_058@163.com.
Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. chenxiaojing_058@163.com.

Per-Olof Hansson (PO)

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Medicine, Geriatrics and Emergency Medicine, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.

Erik Thunström (E)

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Medicine, Geriatrics and Emergency Medicine, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.

Zacharias Mandalenakis (Z)

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Medicine, Geriatrics and Emergency Medicine, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.

Kenneth Caidahl (K)

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Clinical Physiology, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska Universtity Hospital, Stockholm, Sweden.

Michael Fu (M)

Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Medicine, Geriatrics and Emergency Medicine, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH